Skip to main content
HR 2629 107th Congress House

Hematological Cancer Research Investment and Education Act of 2001

Official title: To amend the Public Health Service Act to provide for research, information, and education with respect to blood cancer.

Introduced: July 25, 2001 See on congress.gov
Health Blood diseasesCancerCancer researchDepartment of Health and Human Services
More subjectsShow fewer subjects
Economics and Public FinanceFederal aid to medical researchGovernment Operations and PoliticsGovernment publicityHealth educationLeukemiaResearch centersScience, Technology, Communications
Sign in to write a letter Sign in to watch
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 31, 2001
Referred to the Subcommittee on Health.
Jul 25, 2001
Referred to the House Committee on Energy and Commerce.
Jul 25, 2001
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 31, 2001

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service
Hematological Cancer Research Investment and Education Act of 2001 - Amends the Public Health Service Act to require the Director of: (1) the National Institutes of Health to expand, intensify, and coordinate programs for the conduct and support of research with respect to blood cancer, particularly with respect to leukemia, lymphoma, and multiple myeloma; (2) the Centers for Disease Control and Prevention to establish a related public information program, to be carried out in collaboration with private health organizations that have national education and patient assistance programs on blood-related cancers.
 Related & companion bills 1
  • S 1094 Related bill Hematological Cancer Research Investment and Education Act of 2002
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 17
All 17 Democratic 5 Republican 3
HOEFFEL, JOSEPH
· May 20, 2002
 D
Bishop, Sanford D.
Georgia · May 2, 2002
DOOLEY, CAL
· May 2, 2002
 D
Baldwin, Tammy
Wisconsin · Mar 7, 2002
 R
Capito, Shelley Moore
West Virginia · Mar 7, 2002
TURNER, JIM
· Feb 26, 2002
 R
Graham, Lindsey
South Carolina · Feb 7, 2002
QUINN, JACK
· Feb 5, 2002
 R
Wilson, Joe
South Carolina · Feb 5, 2002
FLETCHER, ERNEST
· Jan 23, 2002
LUCAS, KEN
· Jan 23, 2002
 D
Markey, Edward J.
Massachusetts · Dec 13, 2001
 D
Norton, Eleanor Holmes
District of Columbia · Dec 13, 2001
SCHROCK, EDWARD
· Nov 13, 2001
DUNN, JENNIFER
· Nov 5, 2001
GREENWOOD, JAMES
· Jul 25, 2001
 D
McGovern, James P.
Massachusetts · Jul 25, 2001
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2629: Hematological Cancer Research Investment and Education Act of 2001. 107th Congress. Open America. https://openamerica.io/bill/107-HR-2629/
MLA
"H.R. 2629: Hematological Cancer Research Investment and Education Act of 2001." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-2629/.
Bluebook (legal)
H.R. 2629, 107th Cong. (2026), https://openamerica.io/bill/107-HR-2629/.
Markdown link
[H.R. 2629: Hematological Cancer Research Investment and Education Act of 2001](https://openamerica.io/bill/107-HR-2629/)
Report a problem